CN1294576A - Vla－4拮抗剂 - Google Patents
Vla－4拮抗剂 Download PDFInfo
- Publication number
- CN1294576A CN1294576A CN99803780A CN99803780A CN1294576A CN 1294576 A CN1294576 A CN 1294576A CN 99803780 A CN99803780 A CN 99803780A CN 99803780 A CN99803780 A CN 99803780A CN 1294576 A CN1294576 A CN 1294576A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- aryl
- substituted
- compound
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1233698A | 1998-01-23 | 1998-01-23 | |
| US09/012,336 | 1998-01-23 | ||
| US11072398P | 1998-12-03 | 1998-12-03 | |
| US60/110,723 | 1998-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1294576A true CN1294576A (zh) | 2001-05-09 |
Family
ID=26683440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99803780A Pending CN1294576A (zh) | 1998-01-23 | 1999-01-21 | Vla－4拮抗剂 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1049665A1 (https=) |
| JP (1) | JP4564654B2 (https=) |
| KR (1) | KR20010034317A (https=) |
| CN (1) | CN1294576A (https=) |
| AU (1) | AU746174B2 (https=) |
| BR (1) | BR9907733A (https=) |
| CA (1) | CA2318639A1 (https=) |
| EE (1) | EE200000428A (https=) |
| HU (1) | HUP0100336A3 (https=) |
| ID (1) | ID26665A (https=) |
| IL (1) | IL137329A0 (https=) |
| NO (1) | NO20003694L (https=) |
| WO (1) | WO1999037605A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000043372A1 (en) * | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Acyl derivatives which treat vla-4 related disorders |
| PL350050A1 (en) | 1999-01-22 | 2002-10-21 | Elan Pharm Inc | Acyl derivatives which treat vla-4 related disorders |
| US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| ATE264298T1 (de) | 1999-03-01 | 2004-04-15 | Elan Pharm Inc | Alpha-aminoessigsäure derivate als alpha 4 beta 7-rezeptor antagonisten |
| CA2388686A1 (en) * | 1999-12-07 | 2001-06-14 | Sompong Wattanasin | Vla-4 integrin antagonists |
| EP1244656A1 (en) * | 1999-12-28 | 2002-10-02 | Pfizer Products Inc. | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| DE10019755A1 (de) * | 2000-04-20 | 2001-11-08 | Bayer Ag | Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten |
| GB2367816A (en) | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
| GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
| TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
| TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| TW200610754A (en) * | 2004-06-14 | 2006-04-01 | Daiichi Seiyaku Co | Vla-4 inhibitor |
| GB0523576D0 (en) * | 2005-11-18 | 2005-12-28 | Theradeas Ltd | Drug composition and its use in therapy |
| WO2007101165A1 (en) | 2006-02-27 | 2007-09-07 | Elan Pharmaceuticals, Inc. | Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| EP2124996A4 (en) | 2007-02-20 | 2010-03-24 | Merrimack Pharmaceuticals Inc | METHOD FOR TREATING MULTIPLE SCLEROSIS BY ADMINISTERING AN ALPHA FETOPROTEIN COMBINED WITH AN INTEGRINANT AGONIST |
| CA2721093A1 (en) | 2008-04-11 | 2009-10-15 | Merrimack Pharmaceuticals, Inc. | Human serum albumin linkers and conjugates thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| NZ505363A (en) * | 1997-12-23 | 2005-02-25 | Aventis Pharma Ltd | Compounds containing substituted {2-[3-methoxy-4-(3-o-tolylureido)phenyl]acetylamino}- groups and pharmaceuticals thereof; useful as inhibitors of alpha4beta1 mediated cell division |
-
1999
- 1999-01-21 HU HU0100336A patent/HUP0100336A3/hu unknown
- 1999-01-21 WO PCT/EP1999/000384 patent/WO1999037605A1/en not_active Ceased
- 1999-01-21 CN CN99803780A patent/CN1294576A/zh active Pending
- 1999-01-21 BR BR9907733-7A patent/BR9907733A/pt not_active IP Right Cessation
- 1999-01-21 ID IDW20001404A patent/ID26665A/id unknown
- 1999-01-21 IL IL13732999A patent/IL137329A0/xx unknown
- 1999-01-21 AU AU28292/99A patent/AU746174B2/en not_active Ceased
- 1999-01-21 CA CA002318639A patent/CA2318639A1/en not_active Abandoned
- 1999-01-21 EP EP99908811A patent/EP1049665A1/en not_active Withdrawn
- 1999-01-21 KR KR1020007008039A patent/KR20010034317A/ko not_active Withdrawn
- 1999-01-21 EE EEP200000428A patent/EE200000428A/xx unknown
- 1999-01-21 JP JP2000528529A patent/JP4564654B2/ja not_active Expired - Fee Related
-
2000
- 2000-07-19 NO NO20003694A patent/NO20003694L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20003694L (no) | 2000-09-20 |
| JP2002501039A (ja) | 2002-01-15 |
| AU746174B2 (en) | 2002-04-18 |
| EE200000428A (et) | 2001-12-17 |
| WO1999037605A1 (en) | 1999-07-29 |
| NO20003694D0 (no) | 2000-07-19 |
| BR9907733A (pt) | 2000-10-17 |
| KR20010034317A (ko) | 2001-04-25 |
| EP1049665A1 (en) | 2000-11-08 |
| HUP0100336A2 (hu) | 2001-07-30 |
| HUP0100336A3 (en) | 2002-11-28 |
| IL137329A0 (en) | 2001-07-24 |
| ID26665A (id) | 2001-01-25 |
| AU2829299A (en) | 1999-08-09 |
| JP4564654B2 (ja) | 2010-10-20 |
| CA2318639A1 (en) | 1999-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1294576A (zh) | Vla－4拮抗剂 | |
| BG65755B1 (bg) | Инхибитори на клетъчна адхезия | |
| DE19544687A1 (de) | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| AU2011237421B2 (en) | Inverse agonists and neutral antagonists for the TSH receptor | |
| JP5450407B2 (ja) | 置換アミノ−キナゾリノン、前記化合物を含む薬物、それらの使用及び製造方法 | |
| US20190322633A1 (en) | Stromal derived factor inhibition and cxcr4 blockade | |
| CN101817769B (zh) | 脲基类肽氨肽酶n抑制剂及其应用 | |
| KR102145649B1 (ko) | 구아니디노벤조산 에스테르 화합물 | |
| US5985872A (en) | 2-amino-benzoxazinones for the treatment of viral infections | |
| JP2002538135A (ja) | α４β７レセプターアンタゴニストとして有用なα−アミノ酢酸誘導体 | |
| US7576129B2 (en) | Carboxylic acid compounds | |
| EP1445250A1 (en) | Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same | |
| JP2003534308A (ja) | 新規ｍｍｐ−２／ｍｍｐ−９阻害剤 | |
| EP1496053A1 (en) | Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative | |
| JPWO2017183723A1 (ja) | Ｋｃｎｑ２〜５チャネル活性化剤 | |
| CN101155798A (zh) | Vla-4拮抗剂 | |
| KR20010034168A (ko) | 매트릭스 메탈로프로테이나제 억제제 | |
| KR20010109526A (ko) | 키마제 억제제를 활성 성분으로서 포함하는 각종 호산구증가 관련 질환의 예방 또는 치료제 | |
| PL201421B1 (pl) | Pochodne spiroimidazolidyny, ich zastosowanie i kompozycje farmaceutyczne zawierające pochodne spiroimidazolidyny | |
| JPWO2003002558A1 (ja) | ウイルス感染治療剤 | |
| JPH09188631A (ja) | Ｆａｓリガンド可溶化抑制薬 | |
| JP2003516380A (ja) | Ｖｌａ−４インテグリンアンタゴニスト | |
| US20020091142A1 (en) | Alpha4beta1 and alpha4beta7 integrin inhibitors | |
| WO1999018948A1 (en) | New use of npy antagonists | |
| CN1675169A (zh) | 具有甘氨酸能作用的r(+)－2－氨基－3－羟基丙酸衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Publication of application | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |